VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
15662
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1566
Interactions with Platform & by Email
PARTICIPANTS
313
Unique # Participated
VALIDATIONS
141
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
JULY 2020
TABLES
237
PAGES
781
EDITION
18
PRICE
USD $5450
Is the U.S. Still a Better Global Barometer than China?
Amid the COVID-19 crisis, the global market for Biopharmaceuticals estimated at US$234.5 Billion in the year 2020, is projected to reach a revised size of US$535 Billion by 2027, growing at a CAGR of 12.5% over the analysis period 2020-2027. Monoclonal Antibody, one of the segments analyzed in the report, is projected to record a 12% CAGR and reach US$184.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Interferon segment is readjusted to a revised 12.3% CAGR for the next 7-year period.
The Biopharmaceuticals market in the U.S. is estimated at US$63.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$117.4 Billion by the year 2027 trailing a CAGR of 16.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.8% and 10.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.8% CAGR.
In the global Insulin segment, USA, Canada, Japan, China and Europe will drive the 12.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$28.2 Billion in the year 2020 will reach a projected size of US$62.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$79.4 Billion by the year 2027, while Latin America will expand at a 14.2% CAGR through the analysis period. We bring years of research experience to this 18th edition of our report. The 781-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Abbott Diagnostics, Inc. - Core Laboratory; Amgen, Inc.; Biogen, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche AG; Johnson & Johnson; Merck & Co., Inc.; Novo Nordisk A/S; Pfizer, Inc.; Sanofi
» Product (Monoclonal Antibody, Interferon, Insulin, Growth & Coagulation Factor, Erythropoietin, Vaccine, Hormone, and Others) » Application (Oncology, Blood Disorder, Metabolic Disease, Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology, and Others)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Biopharmaceuticals Competitor Market Share Scenario Worldwide (in %): 2019 & 2028 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Biopharmaceuticals Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Biopharmaceuticals Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017 |
| Biopharmaceuticals Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
| Monoclonal Antibody (Product) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Monoclonal Antibody (Product) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
| Monoclonal Antibody (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Interferon (Product) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025 |
| Interferon (Product) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017 |
| Interferon (Product) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
| Insulin (Product) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025 |
| Insulin (Product) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017 |
| Insulin (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Growth & Coagulation Factor (Product) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025 |
| Growth & Coagulation Factor (Product) Market Historic Review by Region/Country in US$ Million: 2009 to 2017 |
| Growth & Coagulation Factor (Product) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
| Erythropoietin (Product) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Erythropoietin (Product) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
| Erythropoietin (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Vaccine (Product) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025 |
| Vaccine (Product) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017 |
| Vaccine (Product) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025 |
| Hormone (Product) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025 |
| Hormone (Product) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017 |
| Hormone (Product) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Other Products (Product) World Market by Region/Country in US$ Million: 2018 to 2025 |
| Other Products (Product) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017 |
| Other Products (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Oncology (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025 |
| Oncology (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017 |
| Oncology (Application) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
| Blood Disorder (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025 |
| Blood Disorder (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017 |
| Blood Disorder (Application) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025 |
| Metabolic Disease (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025 |
| Metabolic Disease (Application) Global Historic Analysis in US$ Million by Region/Country: 2009-2017 |
| Metabolic Disease (Application) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Infectious Disease (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025 |
| Infectious Disease (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2009 to 2017 |
| Infectious Disease (Application) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025 |
| Cardiovascular Disease (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025 |
| Cardiovascular Disease (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017 |
| Cardiovascular Disease (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Neurological Disease (Application) Worldwide Sales in US$ Million by Region/Country: 2018-2025 |
| Neurological Disease (Application) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017 |
| Neurological Disease (Application) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025 |
| Immunology (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025 |
| Immunology (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017 |
| Immunology (Application) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
| Other Applications (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025 |
| Other Applications (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017 |
| Other Applications (Application) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| United States |
| Market Facts & Figures |
| US Biopharmaceuticals Market Share (in %) by Company: 2019 & 2025 |
| United States Biopharmaceuticals Market Estimates and Projections in US$ Million by Product: 2018 to 2025 |
| Biopharmaceuticals Market in the United States by Product: A Historic Review in US$ Million for 2009-2017 |
| United States Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| United States Biopharmaceuticals Latent Demand Forecasts in US$ Million by Application: 2018 to 2025 |
| Biopharmaceuticals Historic Demand Patterns in the United States by Application in US$ Million for 2009-2017 |
| Biopharmaceuticals Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025 |
| Canada |
| Canadian Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025 |
| Canadian Biopharmaceuticals Historic Market Review by Product in US$ Million: 2009-2017 |
| Biopharmaceuticals Market in Canada: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025 |
| Canadian Biopharmaceuticals Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Biopharmaceuticals Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 |
| Canadian Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Japan |
| Japanese Market for Biopharmaceuticals: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025 |
| Biopharmaceuticals Market in Japan: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017 |
| Japanese Biopharmaceuticals Market Share Analysis by Product: 2009 VS 2019 VS 2025 |
| Japanese Demand Estimates and Forecasts for Biopharmaceuticals in US$ Million by Application: 2018 to 2025 |
| Japanese Biopharmaceuticals Market in US$ Million by Application: 2009-2017 |
| Biopharmaceuticals Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025 |
| China |
| Chinese Biopharmaceuticals Market Growth Prospects in US$ Million by Product for the Period 2018-2025 |
| Biopharmaceuticals Historic Market Analysis in China in US$ Million by Product: 2009-2017 |
| Chinese Biopharmaceuticals Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Chinese Demand for Biopharmaceuticals in US$ Million by Application: 2018 to 2025 |
| Biopharmaceuticals Market Review in China in US$ Million by Application: 2009-2017 |
| Chinese Biopharmaceuticals Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| France |
| Biopharmaceuticals Market in France by Product: Estimates and Projections in US$ Million for the Period 2018-2025 |
| French Biopharmaceuticals Historic Market Scenario in US$ Million by Product: 2009-2017 |
| French Biopharmaceuticals Market Share Analysis by Product: 2009 VS 2019 VS 2025 |
| Biopharmaceuticals Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025 |
| French Biopharmaceuticals Historic Market Review in US$ Million by Application: 2009-2017 |
| French Biopharmaceuticals Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| Europe |
| Market Facts & Figures |
| European Biopharmaceuticals Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Biopharmaceuticals Market Demand Scenario in US$ Million by Region/Country: 2018-2025 |
| Biopharmaceuticals Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017 |
| European Biopharmaceuticals Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
| European Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018-2025 |
| Biopharmaceuticals Market in Europe in US$ Million by Product: A Historic Review for the Period 2009-2017 |
| European Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| European Biopharmaceuticals Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Biopharmaceuticals Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 |
| European Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Germany |
| Biopharmaceuticals Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025 |
| German Biopharmaceuticals Historic Market Analysis in US$ Million by Product: 2009-2017 |
| German Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| Biopharmaceuticals Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025 |
| German Biopharmaceuticals Market in Retrospect in US$ Million by Application: 2009-2017 |
| Biopharmaceuticals Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025 |
| Italy |
| Italian Biopharmaceuticals Market Growth Prospects in US$ Million by Product for the Period 2018-2025 |
| Biopharmaceuticals Historic Market Analysis in Italy in US$ Million by Product: 2009-2017 |
| Italian Biopharmaceuticals Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Italian Demand for Biopharmaceuticals in US$ Million by Application: 2018 to 2025 |
| Biopharmaceuticals Market Review in Italy in US$ Million by Application: 2009-2017 |
| Italian Biopharmaceuticals Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| United Kingdom |
| United Kingdom Market for Biopharmaceuticals: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025 |
| Biopharmaceuticals Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017 |
| United Kingdom Biopharmaceuticals Market Share Analysis by Product: 2009 VS 2019 VS 2025 |
| United Kingdom Demand Estimates and Forecasts for Biopharmaceuticals in US$ Million by Application: 2018 to 2025 |
| United Kingdom Biopharmaceuticals Market in US$ Million by Application: 2009-2017 |
| Biopharmaceuticals Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025 |
| Spain |
| Spanish Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025 |
| Spanish Biopharmaceuticals Historic Market Review by Product in US$ Million: 2009-2017 |
| Biopharmaceuticals Market in Spain: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025 |
| Spanish Biopharmaceuticals Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Biopharmaceuticals Market in Spain: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 |
| Spanish Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Russia |
| Russian Biopharmaceuticals Market Estimates and Projections in US$ Million by Product: 2018 to 2025 |
| Biopharmaceuticals Market in Russia by Product: A Historic Review in US$ Million for 2009-2017 |
| Russian Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| Russian Biopharmaceuticals Latent Demand Forecasts in US$ Million by Application: 2018 to 2025 |
| Biopharmaceuticals Historic Demand Patterns in Russia by Application in US$ Million for 2009-2017 |
| Biopharmaceuticals Market Share Breakdown in Russia by Application: 2009 VS 2019 VS 2025 |
| Rest of Europe |
| Rest of Europe Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018-2025 |
| Biopharmaceuticals Market in Rest of Europe in US$ Million by Product: A Historic Review for the Period 2009-2017 |
| Rest of Europe Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| Rest of Europe Biopharmaceuticals Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Biopharmaceuticals Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 |
| Rest of Europe Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Asia-Pacific |
| Asia-Pacific Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Biopharmaceuticals Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017 |
| Asia-Pacific Biopharmaceuticals Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025 |
| Biopharmaceuticals Market in Asia-Pacific by Product: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Asia-Pacific Biopharmaceuticals Historic Market Scenario in US$ Million by Product: 2009-2017 |
| Asia-Pacific Biopharmaceuticals Market Share Analysis by Product: 2009 VS 2019 VS 2025 |
| Biopharmaceuticals Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025 |
| Asia-Pacific Biopharmaceuticals Historic Market Review in US$ Million by Application: 2009-2017 |
| Asia-Pacific Biopharmaceuticals Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| Australia |
| Biopharmaceuticals Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025 |
| Australian Biopharmaceuticals Historic Market Analysis in US$ Million by Product: 2009-2017 |
| Australian Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| Biopharmaceuticals Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025 |
| Australian Biopharmaceuticals Market in Retrospect in US$ Million by Application: 2009-2017 |
| Biopharmaceuticals Market Share Distribution in Australia by Application: 2009 VS 2019 VS 2025 |
| India |
| Indian Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025 |
| Indian Biopharmaceuticals Historic Market Review by Product in US$ Million: 2009-2017 |
| Biopharmaceuticals Market in India: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025 |
| Indian Biopharmaceuticals Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Biopharmaceuticals Market in India: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 |
| Indian Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| South Korea |
| Biopharmaceuticals Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025 |
| South Korean Biopharmaceuticals Historic Market Analysis in US$ Million by Product: 2009-2017 |
| Biopharmaceuticals Market Share Distribution in South Korea by Product: 2009 VS 2019 VS 2025 |
| Biopharmaceuticals Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2018-2025 |
| South Korean Biopharmaceuticals Historic Market Analysis in US$ Million by Application: 2009-2017 |
| Biopharmaceuticals Market Share Distribution in South Korea by Application: 2009 VS 2019 VS 2025 |
| Rest of Asia-Pacific |
| Rest of Asia-Pacific Market for Biopharmaceuticals: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025 |
| Biopharmaceuticals Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017 |
| Rest of Asia-Pacific Biopharmaceuticals Market Share Analysis by Product: 2009 VS 2019 VS 2025 |
| Rest of Asia-Pacific Demand Estimates and Forecasts for Biopharmaceuticals in US$ Million by Application: 2018 to 2025 |
| Rest of Asia-Pacific Biopharmaceuticals Market in US$ Million by Application: 2009-2017 |
| Biopharmaceuticals Market Share Shift in Rest of Asia-Pacific by Application: 2009 VS 2019 VS 2025 |
| Latin America |
| Latin American Biopharmaceuticals Market Trends by Region/Country in US$ Million: 2018-2025 |
| Biopharmaceuticals Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017 |
| Latin American Biopharmaceuticals Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025 |
| Latin American Biopharmaceuticals Market Growth Prospects in US$ Million by Product for the Period 2018-2025 |
| Biopharmaceuticals Historic Market Analysis in Latin America in US$ Million by Product: 2009-2017 |
| Latin American Biopharmaceuticals Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Latin American Demand for Biopharmaceuticals in US$ Million by Application: 2018 to 2025 |
| Biopharmaceuticals Market Review in Latin America in US$ Million by Application: 2009-2017 |
| Latin American Biopharmaceuticals Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| Argentina |
| Argentinean Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018-2025 |
| Biopharmaceuticals Market in Argentina in US$ Million by Product: A Historic Review for the Period 2009-2017 |
| Argentinean Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| Argentinean Biopharmaceuticals Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Biopharmaceuticals Market in Argentina: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 |
| Argentinean Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Brazil |
| Biopharmaceuticals Market in Brazil by Product: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Brazilian Biopharmaceuticals Historic Market Scenario in US$ Million by Product: 2009-2017 |
| Brazilian Biopharmaceuticals Market Share Analysis by Product: 2009 VS 2019 VS 2025 |
| Biopharmaceuticals Quantitative Demand Analysis in Brazil in US$ Million by Application: 2018-2025 |
| Brazilian Biopharmaceuticals Historic Market Review in US$ Million by Application: 2009-2017 |
| Brazilian Biopharmaceuticals Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| Mexico |
| Biopharmaceuticals Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025 |
| Mexican Biopharmaceuticals Historic Market Analysis in US$ Million by Product: 2009-2017 |
| Mexican Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| Biopharmaceuticals Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025 |
| Mexican Biopharmaceuticals Market in Retrospect in US$ Million by Application: 2009-2017 |
| Biopharmaceuticals Market Share Distribution in Mexico by Application: 2009 VS 2019 VS 2025 |
| Rest of Latin America |
| Rest of Latin America Biopharmaceuticals Market Estimates and Projections in US$ Million by Product: 2018 to 2025 |
| Biopharmaceuticals Market in Rest of Latin America by Product: A Historic Review in US$ Million for 2009-2017 |
| Rest of Latin America Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| Rest of Latin America Biopharmaceuticals Latent Demand Forecasts in US$ Million by Application: 2018 to 2025 |
| Biopharmaceuticals Historic Demand Patterns in Rest of Latin America by Application in US$ Million for 2009-2017 |
| Biopharmaceuticals Market Share Breakdown in Rest of Latin America by Application: 2009 VS 2019 VS 2025 |
| Middle East |
| The Middle East Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Biopharmaceuticals Market in the Middle East by Region/Country in US$ Million: 2009-2017 |
| The Middle East Biopharmaceuticals Market Share Breakdown by Region/Country: 2009, 2019, and 2025 |
| The Middle East Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025 |
| The Middle East Biopharmaceuticals Historic Market by Product in US$ Million: 2009-2017 |
| Biopharmaceuticals Market in the Middle East: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025 |
| The Middle East Biopharmaceuticals Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025 |
| Biopharmaceuticals Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017 |
| The Middle East Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Iran |
| Iranian Market for Biopharmaceuticals: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2018-2025 |
| Biopharmaceuticals Market in Iran: Historic Sales Analysis in US$ Million by Product for the Period 2009-2017 |
| Iranian Biopharmaceuticals Market Share Analysis by Product: 2009 VS 2019 VS 2025 |
| Iranian Demand Estimates and Forecasts for Biopharmaceuticals in US$ Million by Application: 2018 to 2025 |
| Iranian Biopharmaceuticals Market in US$ Million by Application: 2009-2017 |
| Biopharmaceuticals Market Share Shift in Iran by Application: 2009 VS 2019 VS 2025 |
| Israel |
| Israeli Biopharmaceuticals Market Estimates and Forecasts in US$ Million by Product: 2018-2025 |
| Biopharmaceuticals Market in Israel in US$ Million by Product: A Historic Review for the Period 2009-2017 |
| Israeli Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| Israeli Biopharmaceuticals Addressable Market Opportunity in US$ Million by Application: 2018-2025 |
| Biopharmaceuticals Market in Israel: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017 |
| Israeli Biopharmaceuticals Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Saudi Arabia |
| Saudi Arabian Biopharmaceuticals Market Growth Prospects in US$ Million by Product for the Period 2018-2025 |
| Biopharmaceuticals Historic Market Analysis in Saudi Arabia in US$ Million by Product: 2009-2017 |
| Saudi Arabian Biopharmaceuticals Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Saudi Arabian Demand for Biopharmaceuticals in US$ Million by Application: 2018 to 2025 |
| Biopharmaceuticals Market Review in Saudi Arabia in US$ Million by Application: 2009-2017 |
| Saudi Arabian Biopharmaceuticals Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| United Arab Emirates |
| Biopharmaceuticals Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025 |
| United Arab Emirates Biopharmaceuticals Historic Market Analysis in US$ Million by Product: 2009-2017 |
| Biopharmaceuticals Market Share Distribution in United Arab Emirates by Product: 2009 VS 2019 VS 2025 |
| Biopharmaceuticals Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2018-2025 |
| United Arab Emirates Biopharmaceuticals Historic Market Analysis in US$ Million by Application: 2009-2017 |
| Biopharmaceuticals Market Share Distribution in United Arab Emirates by Application: 2009 VS 2019 VS 2025 |
| Rest of Middle East |
| Biopharmaceuticals Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025 |
| Rest of Middle East Biopharmaceuticals Historic Market Analysis in US$ Million by Product: 2009-2017 |
| Rest of Middle East Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| Biopharmaceuticals Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025 |
| Rest of Middle East Biopharmaceuticals Market in Retrospect in US$ Million by Application: 2009-2017 |
| Biopharmaceuticals Market Share Distribution in Rest of Middle East by Application: 2009 VS 2019 VS 2025 |
| Africa |
| African Biopharmaceuticals Market Estimates and Projections in US$ Million by Product: 2018 to 2025 |
| Biopharmaceuticals Market in Africa by Product: A Historic Review in US$ Million for 2009-2017 |
| African Biopharmaceuticals Market Share Breakdown by Product: 2009 VS 2019 VS 2025 |
| African Biopharmaceuticals Latent Demand Forecasts in US$ Million by Application: 2018 to 2025 |
| Biopharmaceuticals Historic Demand Patterns in Africa by Application in US$ Million for 2009-2017 |
| Biopharmaceuticals Market Share Breakdown in Africa by Application: 2009 VS 2019 VS 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 493 Click here to request a full table of contents and more details on this project. |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com